Carnitor (levocarnitine) NDC 54482-144

NDC codes

FDA NDC Directory

Product NDC (as listed)54482-144Labeler and product segments. Claims need a package NDC.

Product NDC at billing width54482-0144Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
54482-144-07	54482014407	10 BLISTER PACK in 1 CARTON (54482-144-07) / 9 TABLET in 1 BLISTER PACKMarketed from Dec 27, 1985

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carnitor
Generic name (nonproprietary): levocarnitine
Active ingredients: Levocarnitine — 330 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Leadiant Biosciences, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018948
Marketing start: Dec 27, 1985
Listing expires: Dec 31, 2026
Other FDA classes: Carnitine (Chemical structure)
Identifiers: Product ID 54482-144_24e9abdb-6e9d-4f27-9e0f-8e8a3a462615SPL ID 24e9abdb-6e9d-4f27-9e0f-8e8a3a462615SPL set ID d2133bc3-9c15-48bd-8b16-b8995a6a14cdRxCUI 197448, 206346UNII 0G389FZZ9M
Pharmacologic class: Carnitine Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N454482014407 followed by a unit qualifier and the quantity

Package 54482-0144-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 30, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE CARNITOR ® (levocarnitine) is indicated in the treatment of primary systemic carnitine deficiency. In the reported cases, the clinical presentation consisted of recurrent episodes of Reye-like encephalopathy, hypoketotic hypoglycemia, and/or cardiomyopathy. Associated symptoms included hypotonia, muscle weakness and failure to thrive. A diagnosis of primary carnitine deficiency requires that serum, red cell and/or tissue carnitine levels be low and that the patient does not have a primary defect in fatty acid or organic acid oxidation (see CLINICAL PHARMACOLOGY ). In some patients, particularly those presenting with cardiomyopathy, carnitine supplementation rapidly alle…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)